ß÷ßäÉçÇø

You may not have heard about the Killam program but it is one of the most prestigious private philanthropic partnerships in Canada. Overseen by the Killam Trusts, the effort recognizes research excellence and honours researchers who will work together to make the world a better place.

As part of the program, the Killam Accelerator Research Award is awarded to an early career faculty member for a three-year term based on the outstanding promise demonstrated by a combination of research output and impact. It hasn’t been awarded to a Faculty of Medicine & Dentistry member since 2019 yet this year, the University found a Faculty of Medicine & Dentistry researcher who deserved this recognition.

Dr. Anastassia Voronova is this year’s recipient.

Dr. Voronova’s research focuses on unlocking the potential of resident neural stem cells to regenerate brain tissue, particularly through the formation of oligodendrocytes—cells essential for myelin production and healthy neuronal function. Her lab’s research has impact and implications on several neurological conditions including multiple sclerosis, autism spectrum disorder, and Alzheimer’s disease. Her work has already been cited in diagnostic policies and may one day demonstrate a new treatment path using regenerative medicine.

“This award is a tremendous honor and a powerful endorsement of our mission to translate fundamental discoveries into novel therapeutic strategies,” said Dr. Voronova. “We aim to understand how the brain builds itself, so we can help it rebuild after injury or disease.”

The Killam Accelerator Award provides $75,000 annually for three years. It aligns with the Faculty of Medicine & Dentistry’s strategic goals to foster innovation, support emerging leaders, and promote interdisciplinary research excellence. It also demonstrates a commitment to ensuring access, community and belonging to valued early career researchers.